Owlstone Medical Raises $7M to Commercialize Disease Breathalyzer

News   Jun 29, 2016

 
Owlstone Medical Raises $7M to Commercialize Disease Breathalyzer
 
 
 

RELATED ARTICLES

Microanalysis of Biological Samples for Early Disease Detection

News

A group of researchers from Osaka University has now developed a nonlinear optical crystal (NLOC) chip, which combines THz waves with a microfluidic device, utilizing the close proximity of the THz wave source and the solution of interest in a microchannel.

READ MORE

New Blood and Urine Tests Indicate Autism in Children

News

New tests, developed by researchers at the University of Warwick, could lead to earlier diagnosis of the condition.

READ MORE

Specific Set of Nerve Cells Controls Seizures’ Spread Through Brain

News

This discovery could lead to new and better treatments for epilepsy.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE